CVS HEALTH CORPORATION (CVS)
What changed this quarter
- Institutions — 1 reduced
- Risk factors — 2 added · 10 removed · new: We may face increased regulatory risks rela… +1
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Company overview
CVS Health. An integrated healthcare company combining the largest US pharmacy chain with Aetna health insurance.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
CVS HEALTH CORPORATION is classified under the Biotech & Health sector. See peers below.
CVS HEALTH CORPORATION key financials
Based on SEC filings · latest quarter (TTM)
Tap a metric name to see its meaning in the glossary.
ETFs holding CVS HEALTH CORPORATION
Per SEC N-PORT · 2026-03-31 · by weight · factual
CVS on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — valuation and growth vs the Biotech & Health average
Peers · Biotech & Health
CVS FAQ
What is CVS HEALTH CORPORATION (CVS)?
CVS Health. An integrated healthcare company combining the largest US pharmacy chain with Aetna health insurance.
What sector is CVS HEALTH CORPORATION in?
CVS HEALTH CORPORATION is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are CVS HEALTH CORPORATION's key financials?
Based on the latest quarter (TTM) from SEC filings: Revenue growth (YoY) 7.6%, Operating margin 4.7%, Net margin 0.7%, ROE 2.4%, Debt-to-equity 0.98x. Definitions and interpretation are available on Stocklore.
Where can I analyze CVS HEALTH CORPORATION (CVS) stock?
On Stocklore you can see CVS's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, 45-day delay), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.